Bilibili (NASDAQ:BILI) Downgraded by Nomura

Nomura cut shares of Bilibili (NASDAQ:BILI – Free Report) from a buy rating to a neutral rating in a report released on Wednesday, Marketbeat reports. A number of other research firms have also recently issued reports on BILI. UBS Group decreased their target price on Bilibili from $23.00 to $22.00 and set a buy rating […]

Leave a Reply

Your email address will not be published.

Previous post Fortress Biotech (NASDAQ:FBIO) PT Lowered to $15.00 at Roth Mkm
Next post Avista (NYSE:AVA) Rating Increased to Hold at StockNews.com